Clinical efficacy of Kuntai capsules combined with tibolone for treating menopausal syndrome
10.3969/j.issn.1005-1678.2017.10.018
- VernacularTitle:替勃龙联合坤泰胶囊治疗绝经综合征的疗效观察
- Author:
Li YAN
1
;
Juan CHENG
;
Jing ZHANG
;
fang Wen DU
;
hua Yao LU
;
jun Xiu ZHANG
;
Bo LI
Author Information
1. 西安医学院附属宝鸡医院 妇产科
- Keywords:
Kuntai capsules;
tibolone;
menopausal syndrome
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(10):48-50
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the efficacy of Kuntai capsules combined with tibolone in treating menopausal syndrome. Methods 80 cases of gynaecology patients from January 2014 to December 2016 were selected and randomly divided into the treatment group and the control group, 40 cases in each group. The treatment group was given Kuntai capsules combined with tibolone, the control group was given tibolone. Results After treatment,the Kupperman scores of the two groups were better than before treatment (P<0.05), the total effective of the treatment group was significantly higher than that of the control group (P<0.05). The number of women who reduced dosage of tibolone in the treatment group was more than in the control group (P<0.05). Conclusion Kuntai capsules combined with tibolone is better in treating menopausal syndrome than tibolone treatment.
